Int. Journal of Clinical Pharmacology and Therapeutics, Volume 64 (2026) - June (296 - 303)

Can tiotropium add-on inhalation revolutionize therapy in elderly asthmatic patients? A treatable traits approach towards successful aging

Yoshihisa Ishiura1, 2, Shosaku Nomura1, 2, Noriyuki Ohkura3, Johsuke Hara3, Masaki Fujimura3, Tomoki Ito1, 2
1 First Department of Internal Medicine, 2 Respiratory Medicine, Kansai Medical University Medical Center, Osaka, and 3 Respiratory Medicine, Kanazawa University Hospital, Kanazawa, Japan

Add to Cart  

 

DOI 10.5414/CP204911

Abstract

Background: The population of elderly patients with asthma is increasing, resulting in serious health problems because of hospitalization and high mortality rate. Furthermore, several recent studies have shown that progressive airflow limitation may worsen cognitive dysfunction and contribute to poor asthma control. Maintaining good respiratory function is therefore important in the elderly in order to achieve a satisfactory quality of life.
Materials and methods: A 12-week, open-label, cross-over study was conducted in elderly patients with asthma to investigate the effect of 5 μg/day tiotropium bromide (TIO) add-on therapy administered using a soft mist inhaler (SMI), in addition to a dosage of 500/20 µg/day fluticasone propionate/formoterol fumarate (FP/FM) treatment and to compare the effects of treatment with those following the administration of 500/20 µg/day FP/FM alone. The trial design thus entailed a 4-week run-in period and two 4-week treatment periods.
Results: A total of 21 patients aged over 65 years with stable bronchial asthma were recruited in the study. Forced expiratory volume in 1 second values after the treatment period with FP/FM and TIO add-on therapy were significantly higher than those after the run-in period (p < 0.01).
Conclusion: TIO add-on therapy FP/FM treatment using an SMI in elderly patients with asthma improved lung function parameters demonstrating, the value of TIO add-on therapy as a treatable traits option for improving quality of life and achieving successful aging in this population.

Author Details

Authors

Departments

  • 1 First Department of Internal Medicine,
  • 2 Respiratory Medicine, Kansai Medical University Medical Center, Osaka, and
  • 3 Respiratory Medicine, Kanazawa University Hospital, Kanazawa, Japan

Address

Yoshihisa Ishiura, MD
First Department of Internal Medicine
Kansai Medical University
10-15 Fumizono-cho, Moriguchi,
Osaka, 570-8507, Japan
Email: [email protected]

Citation

Yoshihisa Ishiura, Shosaku Nomura, Noriyuki Ohkura, Johsuke Hara, Masaki Fujimura, Tomoki Ito.Can tiotropium add-on inhalation revolutionize therapy in elderly asthmatic patients? A treatable traits approach towards successful aging
. Int J Clin Pharmacol Ther. 2026; 64: 296-303. doi: 10.5414/CP204911. Pubmed: https://pubmed.ncbi.nlm.nih.gov/41841282/; PMID: 41841282.

###article_not_exists_msg###

Shopping Overview

Shopping Overview
Type Qtty Discount VAT Price
Your basket is empty
View Cart